Bioatla, INC. (BCAB) SEC Filings — 2025
15 SEC filings for Bioatla, INC. (BCAB) in 2025.
Filings
- BioAtla Files 8-K: Material Agreement, Equity Sales — 8-K · Dec 31, 2025
- BioAtla Files 8-K for Shareholder Vote and Other Events — 8-K · Dec 30, 2025
- BioAtla Seeks Shareholder Nod for Equity Raise, Reverse Split to Avoid Delisting — DEF 14A · Dec 5, 2025
- BioAtla Enters Material Definitive Agreement — 8-K · Nov 21, 2025
- BioAtla's Cash Dries Up Amidst Zero Revenue, Going Concern Doubts — 10-Q · Nov 13, 2025
- BioAtla, Inc. Files 8-K Under 'Other Events' — 8-K · Sep 22, 2025
- BioAtla Burns Cash on R&D, Reports $57.2M Net Loss in Q2 — 10-Q · Aug 7, 2025
- Bain Capital to Acquire BioAtla for $1.00/Share — 8-K · Jun 20, 2025
- BioAtla Faces Delisting Concerns — 8-K · May 16, 2025
- BioAtla, Inc. Q1 2025 10-Q Filing — 10-Q · May 6, 2025
- BioAtla Executive Compensation Details Revealed — DEF 14A · Apr 24, 2025
- BioAtla Files 2024 10-K, Details BeiGene Deal — 10-K · Mar 28, 2025
- BioAtla, Inc. Files 8-K Report — 8-K · Mar 27, 2025
- BioAtla Appoints New CEO, CMO, and Directors — 8-K · Mar 14, 2025
- BioAtla Faces Delisting Concerns — 8-K · Feb 7, 2025